Safety and Tolerability of Azilsartan Medoxomil Plus Chlorthalidone Compared to Olmesartan Medoxomil Plus Hydrochlorothiazide in Participants With Essential Hypertension

NCT00996281 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

837

Enrollment

INDUSTRY

Sponsor class

Conditions

Essential Hypertension

Interventions

DRUG: Azilsartan medoxomil and chlorthalidone
DRUG: Olmesartan medoxomil and hydrochlorothiazide

Sponsor

Takeda